Clinical Trial: Study of CM383 in Healthy Subjects

U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07292688) titled 'Study of CM383 in Healthy Subjects' on Dec. 03.

Brief Summary: This study is a Phase I, single-center, randomized, open-label, parallel-controlled study, aimed at evaluating the pharmacokinetics, pharmacodynamics, immunogenicity, safety, and tolerability of a single dose of CM383 administered via intravenous infusion or subcutaneous injection in healthy male subjects.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: BIOLOGICAL: CM383

CM383 subcutaneous injection, once.

BIOLOGICAL: CM383

CM383 intravenous infusion, once.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Keymed Bioscien...